- Filed
- Apr 23, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 2.41B sh |
| Long Term Debt | Q1 2025 · Mar 30, 2025 | $38.36B |
| Long Term Debt | Q1 2025 · Dec 29, 2024 | $30.65B |
| Short Term Debt | Q1 2025 · Mar 30, 2025 | $13.9B |
| Short Term Debt | Q1 2025 · Dec 29, 2024 | $5.98B |
| Cash And Equivalents | Q1 2025 · Mar 30, 2025 | $38.47B |
| Cash And Equivalents | Q1 2025 · Dec 29, 2024 | $24.11B |
| Stockholders Equity | Q1 2025 · Mar 30, 2025 | $78.11B |
| Stockholders Equity | Q1 2025 · Dec 29, 2024 | $71.49B |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $56.9B |
| Current Liabilities | Q1 2025 · Dec 29, 2024 | $50.32B |
| Total Liabilities | Q1 2025 · Mar 30, 2025 | $115.56B |
| Total Liabilities | Q1 2025 · Dec 29, 2024 | $108.61B |
| Current Assets | Q1 2025 · Mar 30, 2025 | $71.55B |
| Current Assets | Q1 2025 · Dec 29, 2024 | $55.89B |
| Total Assets | Q1 2025 · Mar 30, 2025 | $193.67B |
| Total Assets | Q1 2025 · Dec 29, 2024 | $180.1B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 2.43B sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $1.48B |
| Capex | Q1 2025 · Mar 31, 2024 | $807M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $3.66B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.34 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.35 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $5.26B |
| Net Income | Q1 2025 · Mar 31, 2024 | $3.26B |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $14.87B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $6.51B |
| Revenue | Q1 2025 · Mar 31, 2024 | $21.38B |